Literature DB >> 11759652

Ovarian cancer, oral contraceptives, and BRCA mutations.

S A Narod, P Sun, H A Risch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11759652     DOI： 10.1056/NEJM200112063452312

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

Review 2.  Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Authors:  Tara M Friebel; Susan M Domchek; Timothy R Rebbeck
Journal:  J Natl Cancer Inst       Date:  2014-06       Impact factor: 13.506

Review 3.  Hereditary ovarian cancer in Ashkenazi Jews.

Authors:  Luis Robles-Díaz; Deborah J Goldfrank; Noah D Kauff; Mark Robson; Kenneth Offit
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 4.  Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.

Authors:  Karen H Lu
Journal:  Fam Cancer       Date:  2007-07-17       Impact factor: 2.375

5.  Selected aspects of genetic counselling for BRCA1 mutation carriers.

Authors:  Jacek Gronwald
Journal:  Hered Cancer Clin Pract       Date:  2007-03-15       Impact factor: 2.857

6.  Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.

Authors:  A S Whittemore; R R Balise; P D P Pharoah; R A Dicioccio; I Oakley-Girvan; S J Ramus; M Daly; M B Usinowicz; K Garlinghouse-Jones; B A J Ponder; S Buys; R Senie; I Andrulis; E John; J L Hopper; M S Piver
Journal:  Br J Cancer       Date:  2004-11-29       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.